Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
64,725,654
-
Shares change
-
-22,738,808
-
Total reported value, excl. options
-
$33,190,425
-
Value change
-
-$41,739,808
-
Put/Call ratio
-
2.1%
-
Number of buys
-
44
-
Number of sells
-
67
-
Price
-
$0.5128
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2023
As of 31 Dec 2023 Atara Biotherapeutics, Inc. - Common Stock (ATRA) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,725,654 shares of stock of the company.
Largest 10 holders included EcoR1 Capital, LLC, Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, UBS Group AG, AQR CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, JPMORGAN CHASE & CO, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 89 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.